These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31467485)
1. IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells. Wang Z; Liu G; Mao J; Xie M; Zhao M; Guo X; Liang S; Li H; Li X; Wang R Mediators Inflamm; 2019; 2019():5497467. PubMed ID: 31467485 [TBL] [Abstract][Full Text] [Related]
2. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma. Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751 [TBL] [Abstract][Full Text] [Related]
3. Inhibiting IGF-1R attenuates cell proliferation and VEGF production in IGF-1R over-expressing EGFR mutant non-small cell lung cancer cells. Yeo CD; Kim YA; Lee HY; Kim JW; Lee SH; Kim SJ; Kwon SS; Kim YH; Kim SC Exp Lung Res; 2017 Feb; 43(1):29-37. PubMed ID: 28394654 [TBL] [Abstract][Full Text] [Related]
4. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671 [TBL] [Abstract][Full Text] [Related]
5. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model. Yin SC; Guo W; Tao ZZ Biochem Biophys Res Commun; 2013 Sep; 439(1):1-5. PubMed ID: 23973483 [TBL] [Abstract][Full Text] [Related]
6. IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer. Kruger DT; Alexi X; Opdam M; Schuurman K; Voorwerk L; Sanders J; van der Noort V; Boven E; Zwart W; Linn SC Int J Cancer; 2020 Apr; 146(8):2348-2359. PubMed ID: 31490549 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines. Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861 [TBL] [Abstract][Full Text] [Related]
8. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells. Li X; Liu H; Wang J; Qin J; Bai Z; Chi B; Yan W; Chen X Phytother Res; 2018 Nov; 32(11):2214-2225. PubMed ID: 30069933 [TBL] [Abstract][Full Text] [Related]
9. Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κB signaling in esophageal squamous cell carcinoma. Wu J; Chen K; Zhang F; Jin J; Zhang N; Li D; Ying L; Chen W; Yu H; Mao W; Su D Cancer Med; 2017 Jun; 6(6):1353-1361. PubMed ID: 28440057 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma. Zhao Z; Wen J; Peng L; Liu H Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070 [TBL] [Abstract][Full Text] [Related]
11. Periodic Mechanical Stress Stimulates Cav-1-Dependent IGF-1R Mitogenic Signals in Rat Chondrocytes Through ERK1/2. Ren K; Tang J; Jiang X; Sun H; Nong L; Shen N; Gu Y Cell Physiol Biochem; 2018; 48(4):1652-1663. PubMed ID: 30078012 [TBL] [Abstract][Full Text] [Related]
12. IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer. De Martino MC; van Koetsveld PM; Feelders RA; de Herder WW; Dogan F; Janssen JAMJL; Hofste Op Bruinink D; Pivonello C; Waaijers AM; Colao A; de Krijger RR; Pivonello R; Hofland LJ Endocrine; 2019 Jun; 64(3):673-684. PubMed ID: 30838516 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Sabbatini P; Rowand JL; Groy A; Korenchuk S; Liu Q; Atkins C; Dumble M; Yang J; Anderson K; Wilson BJ; Emmitte KA; Rabindran SK; Kumar R Clin Cancer Res; 2009 May; 15(9):3058-67. PubMed ID: 19383820 [TBL] [Abstract][Full Text] [Related]
14. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128 [TBL] [Abstract][Full Text] [Related]
15. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290 [TBL] [Abstract][Full Text] [Related]
17. Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer. Kang J; Guo Z; Zhang H; Guo R; Zhu X; Guo X Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142299 [TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models. Flanigan SA; Pitts TM; Eckhardt SG; Tentler JJ; Tan AC; Thorburn A; Leong S Clin Cancer Res; 2010 Nov; 16(22):5436-46. PubMed ID: 20943761 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of repression of 11β-hydroxysteroid dehydrogenase type 1 by growth hormone in 3T3-L1 adipocytes. Muraoka T; Hizuka N; Fukuda I; Ishikawa Y; Ichihara A Endocr J; 2014; 61(7):675-82. PubMed ID: 24759003 [TBL] [Abstract][Full Text] [Related]
20. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site. Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]